Guardian Pharmacy Services (NYSE:GRDN) Issues Quarterly Earnings Results

Guardian Pharmacy Services (NYSE:GRDNGet Free Report) announced its quarterly earnings results on Wednesday. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.01), Zacks reports. The business had revenue of $321.10 million for the quarter, compared to the consensus estimate of $329.85 million.

Guardian Pharmacy Services Stock Performance

NYSE:GRDN traded up $0.24 during trading hours on Thursday, reaching $20.47. 17,662 shares of the company traded hands, compared to its average volume of 153,056. The firm’s 50-day simple moving average is $20.54. Guardian Pharmacy Services has a 1-year low of $14.16 and a 1-year high of $25.74.

About Guardian Pharmacy Services

(Get Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

Recommended Stories

Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.